DSS Takara Bio India Pvt. Ltd.

DSS Takara Bio India Pvt. Ltd. is a joint venture between DSS Imagetech Pvt. Ltd. and Takara Bio Inc., established in 2011 with the aim of manufacturing and marketing Takara Bio research kits and reagents in India, in order to more adequately address the needs of the local scientific community.

DSS Imagetech Pvt. Ltd. (formerly known as Darbara Singh & Sons) has been serving the Indian life sciences research fraternity for more than 50 years as a supplier of equipment and consumables from world-renowned companies from around the globe and has been representing Takara Bio Inc. in India since 2005.

Our corporate office and manufacturing facility are both located in New Delhi, and we have a presence in 9 major cities in India (Delhi, Chandigarh, Kolkata, Mumbai, Pune, Hyderabad, Chennai, Bangalore, Trivandrum), with sales representatives situated in several other locations. Our highly qualified team includes a dedicated salesforce, applications specialists with extensive scientific expertise, a capable logistics group that is well-versed in handling both instruments and consumables, and our partners in Japan, who provide invaluable technological know-how.

The formation of DSS Takara Bio India Pvt. Ltd. was made possible through your support, and going forward we will continue to provide the Takara, Clontech, and Cellartis-branded products you have come to rely on for your research, in addition to comprehensive product lines from world-class partners such as Macherey-Nagel and Promocell. At DSS Takara Bio India Pvt. Ltd., customer success will always be our primary objective.

Click here to know more about the products and services offered by DSS Takara Bio India (DTI)

Upcoming WorkShops/Webinars

Webinar : Monitoring the immune response to viral infection by NGS Kits from Takara Bio

                                                                          Register here 

Overview:

During viral pandemics, next-generation sequencing (NGS) can be a valuable tool to help researchers and clinicians understand immune response to infection and treatments. To understand host response when a virus enters the body and later when a treatment is administered, it is important to understand how the transcriptional profiling of a host cell changes. For SARS-CoV-2 it will be important to see how the B cells and T cells are affected to understand what is going on with the immune system. As the number of patients infected with SARS-CoV-2 continues to rise, identifying, evaluating, and understanding the immune response to SARS-CoV-2 infection becomes even more essential. Several questions remain to be answered, such as: are there changes in the clonotype numbers? What clonotypes are present? What effect does the infection have on the diversity of these clonotypes? When treatment is administered, how does the clonotype diversity change?

Our human BCR and TCR kits and Cogent NGS Immune Profiler Software, a bioinformatic solution tailored to these kits, enable you to answer these and other questions and help ensure we can respond properly now and are prepared for the future.

 In this webinar you will discover:

• Importance of Immune Repertoire study during viral pandemics
• What role does Immune system play in the pathogenesis of COVID-19?
• SMART technology coupled with 5' RACE approach to capture complete V(D)J variable regions of BCR and TCR transcripts
• Cogent NGS Immune Profiler Software

Webinar : Footprint-free gene editing using CRISPR/Cas9 and single-cell cloning of edited human iPS cells

                                                                          Register here 

Webinar : Simplify your RT-PCR using the PrimeScript products from Takara Bio

                                                                          Register here 

Webinar : Purification of environmental DNA (eDNA) from water samples

                                                                          Register here